Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:49 pm Unchanged |
2024-12-31 | 13G | FibroGen, Inc. FGEN |
Armistice Capital, LLC | 6,800,000 6.750% |
0 (Unchanged) |
Filing History |
| 2025-02-13 6:24 pm Sale |
2024-12-31 | 13G | FibroGen, Inc. FGEN |
PRIMECAP MANAGEMENT CO | 4,616,130 4.580% |
-5,295,101 (-53.43%) |
Filing History |
| 2024-11-14 4:52 pm Sale |
2024-09-30 | 13G | FibroGen, Inc. FGEN |
Armistice Capital, LLC | 6,800,000 6.770% |
-2,964,000 (-30.36%) |
Filing History |
| 2024-11-12 4:01 pm Sale |
2024-09-30 | 13G | FibroGen, Inc. FGEN |
PRIMECAP MANAGEMENT CO | 9,911,231 9.870% |
-4,560,697 (-31.51%) |
Filing History |
| 2024-11-12 2:33 pm Unchanged |
2024-09-30 | 13G | FibroGen, Inc. FGEN |
The Vanguard Group | 5,882,361 5.850% |
0 (Unchanged) |
Filing History |
| 2024-11-04 1:08 pm Unchanged |
2024-09-30 | 13G | FibroGen, Inc. FGEN |
The Vanguard Group | 5,882,361 5.850% |
0 (Unchanged) |
Filing History |
| 2024-11-04 12:11 pm Sale |
2024-09-30 | 13G | FibroGen, Inc. FGEN |
The Vanguard Group | 5,882,361 5.850% |
-1,161,788 (-16.49%) |
Filing History |
| 2024-07-08 4:32 pm Sale |
2024-06-30 | 13G | FibroGen, Inc. FGEN |
BLACKROCK INC BLK |
2,409,650 2.400% |
-4,795,650 (-66.56%) |
Filing History |
| 2024-02-14 3:37 pm Purchase |
2023-12-31 | 13G | FibroGen, Inc. FGEN |
Armistice Capital, LLC | 9,764,000 9.930% |
9,764,000 (New Position) |
Filing History |
| 2024-02-14 10:04 am Sale |
2023-12-31 | 13G | FibroGen, Inc. FGEN |
Point72 Asset Management, L.P. | 1,643,844 1.700% |
-4,637,801 (-73.83%) |
Filing History |
| 2024-02-13 5:04 pm Sale |
2023-12-29 | 13G | FibroGen, Inc. FGEN |
The Vanguard Group | 7,044,149 7.160% |
-2,399,920 (-25.41%) |
Filing History |
| 2024-02-12 4:01 pm Purchase |
2023-12-31 | 13G | FibroGen, Inc. FGEN |
PRIMECAP MANAGEMENT CO | 14,471,928 14.720% |
576,850 (+4.15%) |
Filing History |
| 2024-01-26 4:23 pm Purchase |
2023-12-31 | 13G | FibroGen, Inc. FGEN |
BLACKROCK INC BLK |
7,205,300 7.300% |
71,562 (+1.00%) |
Filing History |
| 2023-07-19 4:47 pm Purchase |
2023-07-13 | 13G | FibroGen, Inc. FGEN |
MILLENNIUM MANAGEMENT LLC | 4,587,813 4.700% |
4,587,813 (New Position) |
Filing History |
| 2023-02-14 4:22 pm Purchase |
2022-12-31 | 13G | FibroGen, Inc. FGEN |
Point72 Asset Management, L.P. | 6,281,645 6.700% |
1,615,538 (+34.62%) |
Filing History |
| 2023-02-09 4:01 pm Purchase |
2022-12-31 | 13G | FibroGen, Inc. FGEN |
PRIMECAP MANAGEMENT CO | 13,895,078 14.790% |
905,955 (+6.97%) |
Filing History |
| 2023-02-09 11:19 am Purchase |
2022-12-30 | 13G | FibroGen, Inc. FGEN |
The Vanguard Group | 9,444,069 10.050% |
58,880 (+0.63%) |
Filing History |
| 2023-02-08 10:05 am Sale |
2022-12-31 | 13G | FibroGen, Inc. FGEN |
First Trust Portfolios L.P. | 2,975,653 3.170% |
-2,341,960 (-44.04%) |
Filing History |
| 2023-02-06 12:37 pm Purchase |
2022-12-31 | 13G | FibroGen, Inc. FGEN |
BLACKROCK INC BLK |
7,133,738 7.600% |
488,196 (+7.35%) |
Filing History |
| 2022-03-09 08:44 am Purchase |
2022-02-28 | 13G | FibroGen, Inc. FGEN |
The Vanguard Group | 9,385,189 10.090% |
349,001 (+3.86%) |
Filing History |